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Abstract  
Sjögren’s syndrome is an autoimmune disease of unknown etiology where immune response to 
self-antigens is believed to result from interactions between genetic and environmental factors. We 
describe the case of a patient who has been diagnosed with Sjögren’s syndrome based on typical 
clinical and immunological parameters. The clinical picture was dominated by the respiratory 
symptoms, and radiographic and multislice computed tomography examination of the chest showed 
certain changes characteristic of pneumoconiosis. Given that the patient has worked in a foundry 
where he has been exposed to the silica dust, he was subject to examination by occupational 
health specialists under the suspicion of lung silicosis, who confirmed the silicosis. This case report 
points to the possible connection between a professional exposure to silica and Sjögren’s 
syndrome. Occupational exposure to silica is a possible risk factor for the development of 
autoimmune diseases, and in the evaluation of patients with connective tissue diseases it is 
important to consider work-related history.  
 
 
 
 
 
 
Introduction 
 
Sjögren’s syndrome is an autoimmune 
inflammatory disease characterized by the dysfunction 
of the exocrine glands and multiorgan involvement. As 
in the other autoimmune diseases, immunological 
response to self-antigens is complex and is assumed 
to occur in the interaction of genetic and 
environmental factors [1, 2]. The effect of chemical, 
physical and biological agents is important subject in 
the etiology of autoimmune diseases [3].The exposure 
to the silica dust is associated with the development of 
respiratory diseases, namely to silicosis, a form of 
progressive pulmonary fibrosis [4]. However, the 
exposure to silica has been studied as a possible risk 
factor for the development of various autoimmune 
diseases, such as rheumatoid arthritis (RA), 
scleroderma, systemic lupus erythematosus (SLE), 
Sjögren’s syndrome and systemic vasculitis [5]. We 
are going to present the case of a patient diagnosed 
with Sjögren’s syndrome and silicosis.  
Case report 
 
A male patient aged 53, a mould founder, was 
first treated at the Clinic for Allergology and 
Immunology, Clinical Centre of Serbia, in March 2014. 
Major complaints were shortness of breath, cough, 
and increased fatigue. These problems were present 
two years back in association with occasional peaks 
of fever, but he didn’t see a doctor until November 
2013. Then, on chest X-ray a bilaterally and diffusely 
expressed interstitial pulmonary pattern with patchy 
and irregular intense shadows were observed, so he 
was referred to pulmonologist. During the treatment at 
the Clinic for Pulmology, Clinical Centre of Serbia, in 
December 2013, spirometrically a restrictive 
ventilation defect was registered with normal 
bronchoscopic test results (no signs of neoplastic 
process, test result of aspirates on acido-resistant 
bacilli negative). Multislice computed tomography 
(MSCT) of the chest showed numerous micronodular 
and macronodular changes and calcifications, partly 
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flown together bilaterally in the lungs, with irregular 
changes in the left lobe which were more compatible 
with thick fibrous changes than with consolidations; 
smaller lymph glands up to 10mm in diameter in 
mediastinum, subcarinally calcified lymph glands up to 
15mm in diameter (Figure 1). Immunoserological 
analyses showed a positive ANA-IIF using HEp-2 (titer 
1:640), positive anti- SSB antibodies and positive anti 
-SSA antibodies. For this reason, the patient was sent 
to the Clinic for Allergology and Immunology, Clinical 
Centre of Serbia, with a suspected diagnosis of 
systemic connective tissue disease. In personal 
medical history data indicated that he has been 
treated for arterial hypertension, that he is a former 
smoker and consumes alcohol on a daily basis. 
 
Figure 1: Multislice computed tomography of the thorax. 
During the first hospitalization chest 
auscultation revealed diffuse reduced respiratory 
sound, elongation of expirium, an audible high-toned 
wheezing in the upper lung field, and delayed 
inspirium crackles at the bases of both lungs. Other 
physical findings were normal. Laboratory analysis 
registered increased values of the erythrocyte 
sedimentation rate, C-reactive protein, aspartate 
aminotransferase and ferritin; slightly lowered 
hemoglobin and total iron binding capacity; serum iron 
at the lower limit of reference values.The result of 24 h 
proteinuria was within the reference values. Chest X-
ray showed micronodular and stained shadows 
billateraly, partly confluent (Figure 2). The abdominal 
ultrasound showed enlarged liver with 160 mm in the 
right lobe diameter, spleen with 155 mm in 
craniocaudal diameter, without focal changes. The 
ultrasound result did not show any peripheral 
lymphadenopathy. The signs of restrictive respiratory 
disorder were registered spirometrically. Ophtalmo-
logical examination diagnosed keratoconjuctivitis 
sicca (the tear break-up time, Schirmer's test and slit 
lamp examination after rose Bengal staining were 
conducted), whereas the dynamic salivary glands 
scintigraphy showed a reduced accumulative and 
excretory ability of parotid and submandibular glands. 
The patient was diagnosed with Sjögren’s syndrome 
on the basis of the following: subjective feeling of dry 
mouth and eyes lasting longer than three months, 
keratoconjuctivitis sicca, scintigraphic findings of 
reduced accumulative and excretory ability of parotid 
and submandibular glands, positive results of anti- 
SSA and anti-SSB antibodies. The glucocorticoids 
therapy was initiated (prednisolone per os at a dose of 
30 mg a day, and then 20 mg a day), with antimalarial.  
 
Figure 2: Chest X-ray (the first hospitalization). 
 
During the second hospitalization after 4 
months, patient presented with a cough, exhaustion, 
increased fatigue, dryness in the mouth. There was a 
reduced respiratory sound in the lungs, with 
elongation of expirium, rare inspirium crackles, on 
both basal sides. Other findings were normal. 
Laboratory analysis showed increased values of the 
erythrocyte sedimentation rate and ferritin, other 
analyses were normal. A tuberculin skin test was 
negative; there were no acido-resistant bacilli in the 
sputum samples tests.  
 
Figure 3:  Chest X-ray (the second hospitalization). 
 
The virological analysis (HbsAg, anti HCV, 
anti HIV) were negative. Spirometrical signs of 
restrictive respiratory disorder were present, the lung 
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diffusing capacity for carbon monoxide was 
decreased. A repeated chest X-ray showed both-
sided micronodular, partly confluent shadows in the 
lower to middle lung field, flown together into larger 
stained shadows to the right (Figure 3). The 
ultrasound of the heart showed small tricuspid 
regurgitation 1+, and indirectly estimated systolic 
pressure in the right chamber was 45 mmHg. The liver 
and spleen were of normal characteristics and sizes 
on the ultrasound examination. As the patient has 
worked as a mould founder thus being exposed to the 
silica dust, we suspected a lung silicosis. The 
occupational health specialist was consulted, who 
suggested further examinations, which were 
conducted in October 2014. The lung silicosis of 
advanced stages was diagnosed. From the job 
description, it was concluded that the patient was 
exposed to high concentrations of free silica and the 
diagnosis of occupational diseases was made. 
 
 
Discussion 
 
Sjögren’s syndrome is a chronic, autoimmune 
inflammatory disease which primarily affects exocrine 
glands and is characterized by sicca syndrome and 
systemic manifestation. It is assumed that both 
genetic and environmental factors have the role in the 
development of this disease [6, 7]. Although, the 
identification of genetic factors is very important, the 
role of various environmental factors in the 
pathogenesis of autoimmune diseases has been 
extensively studied, including the possible role of 
professional exposure to silica. 
In the early 1950s it was noticed that there 
was a connection between silicosis and rheumatoid 
arthritis, as well as to silicosis and scleroderma [8, 9]. 
Since then, the connection between exposure to silica 
and/or silicosis and autoimmune diseases has 
occupied the attention of scientific community through 
case presentations, epidemiological and experimental 
models studies. However, the exact nature of this 
relationship is not still fully understood.The largest 
number of papers in literature refers to the relationship 
between exposure to silica and scleroderma and RA, 
but an association with SLE, as well as with systemic 
vasculitis has also been noticed. 
In 1993 a group of Spanish authors 
conducted a prospective study on 50 workers from the 
factory for washing powder production with high level 
of silica [10]. The results showed that 32 of them had 
clinical characteristics of the systemic connective 
tissue disease: six with Sjögren’s syndrome, five with 
criteria for systemic sclerosis, three with SLE, five with 
overlap syndrome, and 13 were with insufficiently 
defined systemic disease of connective tissue. 
Antinuclear antibodies were discovered in 72% of the 
tested patients. The presence of antinuclear 
antibodies but also rheumatoid factor in silicosis 
patients was determined by other authors too [11, 12]. 
Rosenman and associates analyzed 463 persons with 
the diagnosis of silicosis and found a diagnose of RA 
in 24 of them, one was with scleroderma and one with 
SLE, that is, in those with silicosis they established a 
prevalence of 5.2% for RA, 0.2% for scleroderma and 
0.2% for SLE [13]. A group of American authors has 
analyzed exposure to silica crystals in 265 patients 
with SLE, and comparing them to the control group, 
established the history of exposure to middle and 
higher levels of silica in 19% of the patients with SLE 
who worked on farms or in dusty trades, and 8% in 
control group [14]. The authors have concluded that in 
some individuals the exposure to silica crystals may 
promote the development of SLE. The American 
Thoracic Society considers that the exposure to silica 
crystals as a possible cause of SLE can be viewed 
only in patients with acute and progressive silicosis 
[15]. Slimani and associates have retrospectively 
analysed the medical records of the patients with 
connective tissue disease and a history of 
occupational exposure to silica [16]. They found four 
patients with scleroderma, three had RA, one SLE 
and one patient had Sjögren’s syndrome. The 
connection between ANCA-associated systemic 
vasculitis and exposure to silica is mostly based on 
case reports. After conducting meta-analysis of the 
current literature, a group of authors concluded that 
there is an association between silica exposure and 
risk for developing ANCA-associated vasculitis [17]. 
The literature data suggests a connection 
between exposure to silica and autoimmune diseases, 
as well as connection between silicosis and 
autoimmune diseases. However, the exact 
mechanism of autoimmune diseases development in 
persons exposed to silica is not entirely known. 
Silicon-dioxide is the most abundant mineral in earth’s 
crust and appears in amorphous and crystal forms. In 
many dusty trades, such as mining, sandblasting, 
granite cutting, tilling, rock drilling, brick laying, there 
is an exposure to respiratory particles of crystalline 
silica. After inhalation, dust particles of silica reach 
alveolar macrophages, where they are phagocyted, 
but because of their extreme toxicity macrophages 
themselves can be destroyed, and activate chronic 
inflammation through immune stimulation [5, 18]. A 
group of American authors has suggested a model in 
which inhalation of silica dust particles leads to 
activation and apoptosis of alveolar macrophages with 
possible consequent liberation of antigens, that is 
further ingested by activated macrophages or 
dendritic cells that are able to migrate to local lymph 
nodes [19]. In the lymph nodes macrophages and 
dendritic cells activate B and T lymphocytes leading to 
the autoimmune response. In the review of their 
experimental studies of patients with silicosis, Lee and 
associates have found the presence of different 
autoantibodies, an alteration of the CD95/Fas 
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molecules, as well as the chronic activation of 
regulatory and responder T lymphocytes after the 
exposure to silica [20].  
Recently, a role of adjuvants in the 
development of autoimmune diseases has been 
considered, and the term Autoimmune/inflammatory 
syndrome induced by adjuvants (ASIA) was 
introduced [21]. Adjuvant is defined as “any substance 
that acts to accelerate, prolong, or enhance antigen 
specific immune response” [22]. This syndrome is 
characterized by symptoms of fatigue, myalgia, 
arthralgia, neurological manifestations, fever, dry 
mouth, and is assumed to be caused by adjuvants, 
such as silicone, tetramethylpentadecane, pristane, 
aluminum [23]. Taking into consideration similar 
clinical characteristics of Sjögren’s syndrome and 
ASIA, their possible connection is also being viewed 
[24]. It was hypothesized that adjuvants can cause 
abnormal immune response directed to the epithelium 
of salivary and lacrimal glands and consequently 
tissue damage. In that context, an exposure to silica 
has been considered as a potential adjuvant in 
pathogenesis of Sjögren’s syndrome [24].  
In the literature, the cases of associated 
exposure to silica and/or silicosis and Sjögren’s 
syndrome are rarely described. In the study of 
Sanchez-Romano and associates Sjögren’s syndrome 
was diagnosed in 6 out of 50 workers, in the study of 
Puisieux and associates there were 3 cases of 
primary Sjögren’s syndrome, one patient with 
Sjögren’s syndrome in the study of Slimani and 
associates, whereas Orriolos and associates have 
described a case of sicca syndrome and 
silicoproteinosis in a dental technician [10, 16, 25, 26]. 
A possible reason for this is that, unlike other systemic 
connective tissue diseases, especially SLE, 
scleroderma and ANCA- associated vasculitis, 
Sjogren's syndrome is characterized by more organ-
specific involvement. The clinical characteristics are 
mostly connected to the dysfunction of exocrine 
glands, and are less related to the lesions of other 
organic systems. Perhaps that is why sicca syndrome, 
joint pain, weakness and exhaustion are not 
considered as a part of a possible Sjögren’s 
syndrome, but as nonspecific symptoms. It should 
also be taken into account that most of the workers in 
mines and in dusty trades are male, so they are less 
suspected of possibly having a Sjögren’s syndrome, 
as it is more common in female persons.  
The exposure to silica contributes to the 
development of autoimmune diseases, such as RA, 
scleroderma, SLE and ANCA-associated vasculitis [3, 
27]. It is not yet clear whether the exposure to silica or 
the silicosis itself predispose the autoimmune disease 
development in some persons, or an autoimmune 
disease is the one that contributes to silicosis in 
persons exposed to silica [5]. It is possible that in 
some individuals with genetic predisposition, exposure 
to the silica is an additional risk factor, the trigger, 
which leads to autoimmune response. In any case, 
the data about professional exposure to silica should 
be carefully considered in the evaluation of patients 
with autoimmune diseases, and vice versa, in silicosis 
patients a possibility for different systemic 
autoimmune diseases should be taken into 
consideration, including Sjogren's syndrome too. 
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